Weil Advised American Securities in the Acquisition of the Life Sciences Division of NN, Inc.

Weil advised American Securities in its $825 million acquisition of the life sciences division of NN, Inc., a diversified industrial company. The transaction closed on October 6, 2020. 

The Weil team that advised American Securities was led by Private Equity Co-Head Douglas Warner and included Private Equity associates Jenna McBainTheodora Tavridou and Hannah Schmitz. The team also included Executive Compensation & Benefits Head Paul Wessel; Banking & Finance partner Andrew Colao; Technology & IP Transactions partner Jeffrey Osterman; Real Estate partner David Herman; Environmental Head Annemargaret Connolly; Employment Litigation Head Gary Friedman; Regulatory Transactions counsel John O’Loughlin and Timothy Welch; Antitrust/Competition counsel Vadim Brusser; Tax associate Maria Smith; Executive Compensation & Benefits associate Radhika Tahiliani; Banking & Finance associate Jeremy Jenkins; Technology & IP Transactions/Privacy associate Maryann Thompson; Real Estate associate Joshua Rudin; International Arbitration & Trade associate Nathan Cunningham; Antitrust/Competition associates Dan Nobil and Elizabeth Ross; and Employment Litigation associate Thomas McCarthy.